Moderna had been awarded over $750 million to develop a vaccine against bird flu, which has been circulating in farm animals and sickening people.

The Trump administration has canceled $766 million awarded to Moderna to develop a vaccine against potential pandemic influenza viruses, including the H5N1 bird flu.

The Trump administration has delivered its latest blow to vaccines, canceling a nearly $600-million contract to the drugmaker Moderna that was intended to develop a shot for humans against bird flu.

The Trump administration has canceled a contract awarded to Moderna for the late-stage development of its bird flu vaccine for humans, as well as the right to purchase shots, the drugmaker announced ...

U.S. Ends $600M Moderna Bird Flu Vaccine Contract THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a vaccine for bird ...

The Department of Health and Human Services is ending a $766 million contract with the vaccine company Moderna to develop an mRNA vaccine for flu strains with pandemic potential, including bird flu.

The Trump administration has terminated a multi-million-dollar contract with Massachusetts-based Moderna to support its late-stage development of a bird flu vaccine for humans. The company ...

Health Secretary Robert F. Kennedy Jr. has expressed deep skepticism regarding mRNA vaccines, despite real-world evidence ...

Moderna has interim data it says support advancing its avian influenza vaccine into a late-stage clinical trial, but the U.S. government has canceled the federal contract that would have financed ...

30 years ago, a boston company will get $170 million to develop to develop a bird flu vaccine. moderna says it will use the same mrna technology used to produce shots for covid 19.

On Wednesday, as news broke that the Trump administration was reneging on the contract, Moderna reported positive results from an early trial of a vaccine targeting H5 influenza viruses. In a ...

Moderna in January was awarded $590 million by the Biden administration to advance the development of its bird flu vaccine, and support the expansion of clinical studies for up to five additional ...